FDA declines to review Moderna application for new flu vaccine
The FDA has declined to review Moderna's application for a new flu vaccine, despite previously giving the project the green light. This decision could have implications for the approval process of all new and updated vaccines in the US. The move comes amid the Trump administration's ongoing actions against vaccines, including the decision in January to stop fully recommending one-third of routine childhood vaccines, including flu shots. Moderna has requested a meeting with the FDA to discuss the refusal, as the decision could set a precedent for the review of future vaccine applications. The article suggests that this decision is the latest in a series of actions by the Trump administration that appear to be undermining the development and approval of new and updated vaccines in the country.
Source: For the complete article, please visit the original source link below.
